Pharmaceuticals

The Rising Burden Of Orthopedic Disorders Fueling Market Growth Due To Increasing Musculoskeletal Disease Prevalence Is Supporting Development Across The Oxycodone Drugs Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Oxycodone Drugs Market Between 2026 And 2030?

The market size for oxycodone drugs has seen robust growth in recent years. It is projected to increase from $5.98 billion in 2025 to $6.38 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. This historical expansion can be attributed to the high prevalence of moderate to severe pain conditions, the widespread use of opioids in post operative care, strong hospital demand for injectable analgesics, the established clinical efficacy of oxycodone, and the limited availability of alternative pain therapies.

The oxycodone drugs market is projected to experience substantial expansion over the coming years, with its valuation anticipated to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This projected growth during the forecast period is primarily driven by factors such as more stringent regulations for opioid prescriptions, the rise of controlled-release pain management solutions, an increase in cancer and chronic pain diagnoses, the proliferation of pain management clinics, and the creation of safer opioid formulations. Significant trends expected in this period encompass a move towards abuse-deterrent oxycodone formulations, increasing adoption of extended-release therapies for pain management, a growing inclination for administering opioids in hospital settings, greater focus on monitoring prescriptions and ensuring compliance, and the broader availability of generic oxycodone products within regulated markets.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

What Are The Main Drivers Accelerating The Growth Of The Oxycodone Drugs Market?

The anticipated increase in orthopedic disorders is poised to drive the expansion of the oxycodone drug market. These conditions encompass ailments impacting bones, joints, ligaments, tendons, and muscles, frequently leading to persistent pain, restricted movement, and enduring functional impairments. Various factors contribute to this rise in orthopedic conditions, including an aging population, inactive lifestyles, obesity, injuries sustained during sports, and work-related stress. Oxycodone medications offer effective pain relief for both acute and chronic orthopedic issues, such as fractures, joint damage, and recovery after surgery, by targeting pain receptors within the central nervous system. For illustration, data from February 2024 provided by Arthritis Australia, a non-profit organization based in Australia, indicates that by 2025, around 212,136 males and 362,137 females are forecast to suffer from rheumatoid arthritis (RA), with these figures anticipated to climb to approximately 280,040 males and 479,828 females by 2040. Consequently, the increasing prevalence of orthopedic disorders is a key factor propelling the expansion of the oxycodone drug market.

How Is The Oxycodone Drugs Market Structured Across Different Market Segments?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

What Trends Are Affecting The Growth Of The Oxycodone Drugs Market?

Leading companies in the oxycodone drug market are prioritizing the development of advanced abuse-deterrent immediate-release (IR) formulations to diminish the risk of misuse through injection and intranasal administration. These abuse-deterrent IR opioids integrate physical and chemical barriers, rendering the tablets difficult to crush, dissolve, or manipulate for non-oral routes, thereby enhancing patient safety and minimizing diversion. For instance, in October 2024, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, obtained FDA approval for ROXYBOND™ (oxycodone hydrochloride) 10 mg immediate-release tablets, which incorporate their patented SentryBond abuse-deterrent technology. This technology is specifically engineered to resist physical manipulation and chemical extraction, making the tablets challenging to cut, crush, or dissolve for misuse via intranasal or intravenous routes. As a result, it reduces the potential for abuse while continuing to provide effective immediate-release pain relief for patients whose severe pain necessitates opioid therapy when other treatment options prove insufficient.

Which Industry Players Are Present In The Oxycodone Drugs Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Access The Complete Oxycodone Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Geographic Region Represents The Largest Oxycodone Drugs Market Share?

North America was the largest region in the oxycodone drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oxycodone Drugs Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Browse Through More Reports Similar to the Global Oxycodone Drugs Market 2026, By The Business Research Company

Oxycodone Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Narcotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/narcotic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795